Diagnostics News and Research RSS Feed - Diagnostics News and Research

Zenalux, RPCI collaborate to enhance Zenascope system to detect oral cancers at an early stage

Zenalux, RPCI collaborate to enhance Zenascope system to detect oral cancers at an early stage

Zenalux Biomedical, Inc., a leader in biophotonic diagnostics, is working with Roswell Park Cancer Institute to further enhance its flagship Zenascopeā„¢ product by adding a high-resolution camera to the system. [More]
Study shows effect of whooping cough vaccination on Bordetella pertussis bacteria

Study shows effect of whooping cough vaccination on Bordetella pertussis bacteria

The most comprehensive study to date of the family of bacteria that causes whooping cough points to more effective vaccine strategies and reveals surprising findings about the bacteria's origin and evolution. The new results could alter public health strategies to control this respiratory disease, which kills 195,000 children worldwide each year. [More]
Roche's cobas HPV Test gets FDA approval for first-line primary screening for cervical cancer

Roche's cobas HPV Test gets FDA approval for first-line primary screening for cervical cancer

Roche announced today that the U.S. Food and Drug Administration approved the cobas HPV (Human Papillomavirus) Test for use as a first-line primary screening test for cervical cancer in women 25 and older. The approval follows the March 12 unanimous recommendation from the Microbiology Devices Panel of the FDA's Medical Devices Advisory Committee, making the cobas HPV Test the first and only HPV test in the United States approved for first-line primary screening. [More]

Liaison Healthcare's EMR-Link solution recognized as a certified Health IT Quality Solution

As a certified Health IT Quality Solution, Liaison Healthcare's EMR-Link solution has been recognized by Quest Diagnostics as meeting or exceeding advanced industry standards for health IT quality and for providing a streamlined, interoperable solution that enables secure clinical laboratory ordering and results reporting through Quest Diagnostics connectivity solutions. [More]
WLSA's Convergence Summit to focus on global adoption of technology-enabled health care

WLSA's Convergence Summit to focus on global adoption of technology-enabled health care

The Wireless-Life Sciences Alliance said today that its ninth annual Convergence Summit here next month will focus on achieving broader global adoption of technology-enabled health care at a time when the pace of innovation in connected health and personal health solutions is accelerating. [More]
Personalis receives CAP accreditation

Personalis receives CAP accreditation

Personalis, Inc., a leading provider of genome-based diagnostics, announced today that its onsite clinical laboratory has received accreditation from the College of American Pathologists (CAP), meeting the highest standard of excellence in clinical laboratory practices. [More]

AMP releases report on recommendations for molecular diagnostics curriculum

The Association for Molecular Pathology (AMP) released a report today in The Journal of Molecular Diagnostics on recommendations for a molecular diagnostics curriculum at both the baccalaureate and master's levels of education. [More]

Studies identify 2 genes highly associated with IBD

Inflammatory Bowel Disease (IBD), a group of chronic inflammatory disorders of the intestine that result in painful and debilitating complications, affects over 1.4 million people in the U.S., and while there are treatments to reduce inflammation for patients, there is no cure. [More]
Automated diagnostic technologies redefine infectious diseases

Automated diagnostic technologies redefine infectious diseases

The diagnostics market for infectious diseases such as tuberculosis (TB), human immunodeficiency virus (HIV), hepatitis C virus and human papilloma virus is expanding, giving rise to commercial opportunities especially in the developing economies of Asia, Africa and Latin America. [More]

Researchers study evolution of harmful organisms from 1 bacterial family

For the first time, researchers have studied the Black Death bacterium's entire family tree to fully understand how some of the family members evolve to become harmful. [More]

Quest Diagnostics acquires Summit Health

Quest Diagnostics, the world's leading provider of diagnostic information services, has completed the previously announced acquisition of Summit Health, a leading provider of on-site prevention and wellness services. Financial terms were not disclosed. [More]

New report analyzes Mobile Medical Apps market worldwide

Global Information Inc. announces the addition of a new market research report "Mobile Medical Apps Trends" at GIIResearch.com [More]

Global biochemistry analyzers market to grow at 4.50% CAGR by 2016

Research and Markets has announced the addition of the "Global Biochemistry Analyzers Market Report" report to their offering. [More]

Research report on flow cytometry market

According to the new market research report "Flow Cytometry Market by Technology (Cell & Bead-based), Products & Services (Reagents, Instruments, Software, & Accessories), Application (Research & Clinical), End User (Commercial Organizations & Diagnostics Laboratories) - Global Forecasts to 2018", analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and Rest of the world (RoW). [More]
Global operating room equipment market estimated to grow at 3.76% CAGR by 2016

Global operating room equipment market estimated to grow at 3.76% CAGR by 2016

Research and Markets has announced the addition of the "Global Operating Room Equipment Market Report" report to their offering. [More]
Cepheid's revenues increase 16% to 106.9 million in first quarter 2014

Cepheid's revenues increase 16% to 106.9 million in first quarter 2014

Cepheid today reported revenues for the first quarter of 2014 of $106.9 million, representing growth of 16% from $91.9 million for the first quarter of 2013. Net loss in the first quarter of 2014 was $(9.3) million, or $(0.13) per share, which compares to net income of $0.3 million, or $0.00 per share, in the first quarter of 2013. [More]
Global cancer profiling market expected to grow $54.8 billion by 2018

Global cancer profiling market expected to grow $54.8 billion by 2018

Global Information Inc. announces the addition of a new market research report "Cancer Profiling and Pathways: Technologies and Global Markets" at GIIResearch.com. [More]

Princeton professor receives Agilent Thought Leader Award to research on cellular metabolism activity

Agilent Technologies Inc. today announced that Joshua Rabinowitz, M.D., Ph.D., professor at Princeton University's Department of Chemistry and the Lewis-Sigler Institute for Integrative Genomics, has received an Agilent Thought Leader Award to support his work on quantitative analysis of cellular metabolism. [More]

SCRA Technology Ventures announces sale of Selah Genomics to EKF Diagnostics

SCRA Technology Ventures today announced that portfolio company Selah Genomics was sold to EKF Diagnostics, a publically-traded UK-based diagnostics firm. Selah, a provider of advanced molecular and genomic diagnostic services, completed the deal today, making it the largest of nine exits out of the SC Launch program since 2006. [More]

OPKO Health enters into definitive agreement to acquire Inspiro Medical

OPKO Health, Inc. has entered into a definitive agreement to acquire Inspiro Medical Ltd., an Israeli medical device company developing a new platform to deliver small molecule drugs such as corticosteroids and beta agonists or larger molecules to treat respiratory diseases. Inspiro's Inspiromatic is a "smart" easy-to-use dry powder inhaler with several advantages over existing devices. [More]